| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Boosting anti-tumor immunity with TILT-517 oncolytic adenovirus and checkpoint blockade in renal cell carcinoma
|
Arias, Victor
|
|
|
33 |
2 |
p.
|
artikel
|
| 2 |
Characterization of a multiplex digital PCR assay to quantify total T cells relative to chimeric antigen receptor-positive T cells
|
Murphy, Lindsey A.
|
|
|
33 |
2 |
p.
|
artikel
|
| 3 |
Cost-effective strategies for CAR-T cell therapy manufacturing
|
Abdo, Luiza
|
|
|
33 |
2 |
p.
|
artikel
|
| 4 |
CRISPR-Cas9 knockout of DGKα/ζ improves the anti-tumor activities of TAG-72 CAR-T cells in ovarian cancer
|
Evtimov, Vera J.
|
|
|
33 |
2 |
p.
|
artikel
|
| 5 |
Dendritic cell targeting in lymph nodes with modular adapters boosts HAdV5 and HC-HAdV5 tumor vaccination by co-secretion of IL-2v and IL-21
|
Weiss, Fabian
|
|
|
33 |
2 |
p.
|
artikel
|
| 6 |
Dual CARM1-and IKZF3-targeting: A novel approach to multiple myeloma therapy
|
Ni, Wei
|
|
|
33 |
2 |
p.
|
artikel
|
| 7 |
Emerging roles of protein arginine methyltransferase in multiple myeloma
|
Qaddoura, Sajida Fady
|
|
|
33 |
2 |
p.
|
artikel
|
| 8 |
Engineered oncolytic virus OH2-FLT3L enhances antitumor immunity via dendritic cell activation
|
Wan, Duo
|
|
|
33 |
2 |
p.
|
artikel
|
| 9 |
Engineered oncolytic virus oHSV2-FLT3L enhances antitumor immunity via dendritic cell activation
|
Wan, Duo
|
|
|
33 |
2 |
p.
|
artikel
|
| 10 |
Engineered retargeting to overcome systemic delivery challenges in oncolytic adenoviral therapy
|
Leparc, Louise
|
|
|
33 |
2 |
p.
|
artikel
|
| 11 |
Engineering a novel HSV-1 strain for oncolytic therapy of solid tumors
|
Vázquez-Arreguín, Karina
|
|
|
33 |
2 |
p.
|
artikel
|
| 12 |
Enhanced anti-tumor activity by zinc finger repressor-driven epigenetic silencing of immune checkpoints and TGFBR2 in CAR-T cells and TILs
|
David, Marion
|
|
|
33 |
2 |
p.
|
artikel
|
| 13 |
Enhancing plasmacytoid dendritic cell functionality with all-trans retinoic acid for improved multiple myeloma therapy
|
Yu, Wanli
|
|
|
33 |
2 |
p.
|
artikel
|
| 14 |
Epstein-Barr virus mRNA vaccine synergizes with NK cells to enhance nasopharyngeal carcinoma eradication in humanized mice
|
Huang, Kun
|
|
|
33 |
2 |
p.
|
artikel
|
| 15 |
ER-mitochondria tethering and its signaling: A novel therapeutic target in breast cancer
|
Paidi, Chamanthi
|
|
|
33 |
2 |
p.
|
artikel
|
| 16 |
Exploiting divergent mechanisms of trabectedin for bone tumors
|
Tolstyka, Zachary P.
|
|
|
33 |
2 |
p.
|
artikel
|
| 17 |
hsa-miR-5688 inhibits FOXC1-OCT4/SOX2 feedforward loop that drives chemoresistance in breast cancer stem cells
|
Dutta, Apratim
|
|
|
33 |
2 |
p.
|
artikel
|
| 18 |
Identification of dynamic network biomarker ITGB1 for erlotinib pre-resistance using single-cell differential covariance entropy
|
Gu, Xuerong
|
|
|
33 |
2 |
p.
|
artikel
|
| 19 |
Intrinsic immunosuppressive features of monocytes suppress CAR-T19 through IL-1 pathway modulation in mantle cell lymphoma
|
Yun, Kun
|
|
|
33 |
2 |
p.
|
artikel
|
| 20 |
K12-ligand-based CAR T cell therapy for CD7-positive T cell malignancies
|
Visser, Nienke
|
|
|
33 |
2 |
p.
|
artikel
|
| 21 |
Neospora caninum as delivery vehicle for anti-PD-L1 scFv-Fc: A novel approach for cancer immunotherapy
|
Riviere, Clément
|
|
|
33 |
2 |
p.
|
artikel
|
| 22 |
Novel immunotherapy for multiple myeloma involving activation of plasmacytoid dendritic cells
|
Kurimoto, Masayuki
|
|
|
33 |
2 |
p.
|
artikel
|
| 23 |
Novel synthetic peptide-based vaccine shows promise against prostate cancer
|
Vázquez-Arreguín, Karina
|
|
|
33 |
2 |
p.
|
artikel
|
| 24 |
Oncolytic adeno-immunotherapy improves allogeneic adoptive HER2.CAR-NK function against pancreatic ductal adenocarcinoma
|
Biegert, Greyson
|
|
|
33 |
2 |
p.
|
artikel
|
| 25 |
Phosphoribosyl transferase domain containing 1: A prognostic biomarker in testicular germ cell tumors
|
Huang, Peisheng
|
|
|
33 |
2 |
p.
|
artikel
|
| 26 |
PLA2G4F is a metabolic checkpoint in triple-negative breast cancer: Insights from multiple omics analysis and experiments
|
Tang, Xun
|
|
|
33 |
2 |
p.
|
artikel
|
| 27 |
Preclinical development and clinical safety assessment of a synthetic peptide conjugate enabling endogenous antibody binding to promote innate receptor engagement
|
Fletcher, Erika A.K.
|
|
|
33 |
2 |
p.
|
artikel
|
| 28 |
Preclinical study of microphthalmia-associated transcription factor inhibitor ML329 in gastrointestinal stromal tumor growth
|
Guerrero, Mario
|
|
|
33 |
2 |
p.
|
artikel
|
| 29 |
Quantitative and qualitative metrics of tumor stroma in predicting ovarian cancer outcomes and expansion of its study with AI-based tools
|
Madill, Morgann
|
|
|
33 |
2 |
p.
|
artikel
|
| 30 |
Real-time imaging reveals radiation-induced intratumor apoptosis via nutrient and oxygen deprivation following vascular damage
|
Kagiya, Go
|
|
|
33 |
2 |
p.
|
artikel
|
| 31 |
Regulation of the brain tumor microenvironment by focused ultrasound
|
Fu, Kang
|
|
|
33 |
2 |
p.
|
artikel
|
| 32 |
Retraction Notice to: The Expression of MicroRNA-598 Inhibits Ovarian Cancer Cell Proliferation and Metastasis by Targeting URI
|
Xing, Feng
|
|
|
33 |
2 |
p.
|
artikel
|
| 33 |
Safety, efficacy and total cost of point-of-care manufactured anti-CD19 CAR-T cell therapy in India: VELCART trial
|
Palani, Hamenth Kumar
|
|
|
33 |
2 |
p.
|
artikel
|
| 34 |
Shared neoantigens for cancer immunotherapy
|
Goloudina, Anastasia
|
|
|
33 |
2 |
p.
|
artikel
|
| 35 |
Splice-modulating strategies targeting the insulin receptor: A novel therapeutic pathway in osteosarcoma
|
Singh, Divya R.
|
|
|
33 |
2 |
p.
|
artikel
|
| 36 |
Systemic therapy with the infectivity-selective oncolytic adenovirus by targeting mesothelin
|
Sato-Dahlman, Mizuho
|
|
|
33 |
2 |
p.
|
artikel
|
| 37 |
Targeted expansion of cytotoxic T cells using IL-12 and CD137L supplementation enhances antitumor efficacy
|
Sanz, Marta
|
|
|
33 |
2 |
p.
|
artikel
|
| 38 |
The multilayered control of acetylation during adenovirus-based immunotherapy of cancer
|
Parthasarathy, Akhila
|
|
|
33 |
2 |
p.
|
artikel
|
| 39 |
The oligosaccharyltransferase complex is an essential component of multiple myeloma plasma cells
|
Nguyen, Hong Phuong
|
|
|
33 |
2 |
p.
|
artikel
|
| 40 |
The safer effector cell? Potential of CD147 CAR NK cells to tackle tumors with lower toxicity
|
Hodges, Alan
|
|
|
33 |
2 |
p.
|
artikel
|
| 41 |
Transcriptome analysis reveals the potential role of neural factor EN1 for long-terms survival in estrogen receptor-independent breast cancer
|
Ren, He
|
|
|
33 |
2 |
p.
|
artikel
|
| 42 |
Tumor-specific AAV delivery of interleukin-12 enhances antitumor immunity and safety in ovarian cancer xenograft mouse model
|
Chen, Chuyuan
|
|
|
33 |
2 |
p.
|
artikel
|
Tijdschrift beschrijving